Carl Zeiss Meditec AG

XETRA:AFX.DE

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🔬 Clinical Trials

🕶 Eyewear

🏥 Hospitals & Clinics

💻 Telehealth

Location

Germany

Market Cap

USD 5.57 B

Share Price

USD 63.67

Avg Daily Volume

178,163

Change (1 day)

0.75%

Change (1 year)

-7.60%

Change (YTD)

34.41%

Carl Zeiss Meditec AG Enterprise Value to EBITDA (EV/EBITDA) on June 23, 2025: 12.69

Carl Zeiss Meditec AG Enterprise Value to EBITDA (EV/EBITDA) is 12.69 on June 23, 2025, a 9.21% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.

Carl Zeiss Meditec AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 15.16 on June 23, 2025, which is 19.51% above the current Enterprise Value to EBITDA (EV/EBITDA).
Carl Zeiss Meditec AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 9.39 on June 23, 2025, which is -25.99% below the current Enterprise Value to EBITDA (EV/EBITDA).
Carl Zeiss Meditec AG average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 11.92.

Daily

From:

To:

Zoom:

Key data

Date	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield	Dividend Yield	Market Capitalization

XETRA: AFX.DE

Carl Zeiss Meditec AG

CEO	Dr. Markus Weber
IPO Date	March 22, 2000
Location	Germany
Headquarters	Goschwitzer Strasse 51-52
Employees	2,066
Sector	🏥 Health Care
Industries Medical Instruments 🔬 Clinical Trials 🕶 Eyewear 🏥 Hospitals & Clinics 💻 Telehealth

Description

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.